For example, not including inflammatory markers such as IL-1, IL-6, or C-reactive protein (CRP), markers of metabolic risk such as C-peptides or insulin resistance index, and oxidative stress markers such as plasma isoprostanes limited the interpretation of our findings to support the antioxidant compensation hypothesis, in particular in subjects with OWOB. The gene discussed is IL6; the disease is Insulin resistance.